BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35359932)

  • 1. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
    Al-Mughales JA
    Front Immunol; 2022; 13():850759. PubMed ID: 35359932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunodiagnostic Utility of Antinuclear Antibody Patterns: A Prediction for Renal Involvement in Systemic Lupus Erythematosus Patients in the Western Region of Saudi Arabia.
    Al-Mughales J
    Cureus; 2023 Aug; 15(8):e43532. PubMed ID: 37719585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Study on Antinuclear Antibody Patterns in Systemic Lupus Erythematosus Patients and Its Correlation With Serological Markers.
    Ramachandran A; Kumar K; Sankaralingam R; Chinnadurai S; Chilukuri B
    Cureus; 2023 Dec; 15(12):e50049. PubMed ID: 38186533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
    Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
    Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
    Almogren A
    Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
    Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
    Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
    Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
    Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
    J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.
    Al-Jabri AA; Al-Gahdani AK; Al-Shuaili I
    Rheumatol Int; 2009 Nov; 30(1):51-6. PubMed ID: 19360411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Anti-nuclear and Anti-phospholipid Antibodies in an Egyptian Cohort with Schizophrenia: A Case-control Study.
    Medhat BM; Abu-Zaid MH; Dorgham D; El-Ghobashy N; Afifi AY; El-Makawi S; Ayoub DR; Khalaf OO; Amer R; Koptan DMT; Maged LA
    Curr Rheumatol Rev; 2022; 18(3):266-271. PubMed ID: 34751124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative ANA-IIF in SLE patients: what is beyond?
    Abozaid HSM; Hefny HM; Abualfadl EM; Ismail MA; Noreldin AK; Eldin ANN; Goda AM; Ali AH
    Clin Rheumatol; 2023 Jul; 42(7):1819-1826. PubMed ID: 37016193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.